Anti-Aging Compound Library (96-Well)

Anti-Aging Compound Library (96-Well)

• Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com Anti-Aging Compound Library (96-well) Product Details: Catalog Number: CS-L034 Formulation: A collection of 2615 anti-aging compounds supplied as pre-dissolved Solutions or Solid Container: 96- or 384-well Plate with Peelable Foil Seal; 96-well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode Storage: -80°C Shipping: Blue ice Packaging: Inert gas Plate layout: CS-L034-1 1 2 3 4 5 6 7 8 9 10 11 12 Fumarate a Empty ML162 ML-210 hydratase-IN- SR-3029 AZD0156 BAY1125976 LY3177833 PQR620 AT-130 MK-4101 Empty 1 Flavopiridol b Empty Flavopiridol (Hydrochlorid SNS-032 Semagacesta KNK437 GLX351322 TA-01 Mitoquinone AZD-5438 Tubercidin Empty e) t (mesylate) Rho-Kinase- c Empty R547 E 2012 SAR-020106 TPEN CP21R7 RSL3 CZ415 SANT-1 ME0328 IN-1 Empty SRI-011381 MELK-8a d Empty Mifobate Nutlin-3a 9-amino-CPT (hydrochlorid EPI-001 Remetinostat (hydrochlorid BH3I-1 NKL 22 Brevianamide Empty e) e) F gamma- Empty PF-04979064 GNF-6231 FCCP CAN508 IMR-1 IMR-1A HA15 secretase WYE-132 HO-3867 Empty e modulator 1 f Empty NSC781406 Visomitin TAK-243 TBHQ BP-1-102 SH5-07 M2698 ITSA-1 NVS-PAK1-1 ML385 Empty D-α- Empty XMU-MP-1 Sp-cAMPS DTP3 DTP3 (TFA) Hydroxyglutar FLLL32 GSK621 (S)-Crizotinib MSDC 0160 Tempol Empty g (sodium salt) ic acid HJC0152 h Empty AGK2 Asaraldehyde CORM-3 Splitomicin D-Glutamine SirReal2 Urolithin A BGG463 hydrochloride AS1517499 Empty Plate layout: CS-L034-2 1 2 3 4 5 6 7 8 9 10 11 12 Y-33075 a Empty BVT948 Y-33075 L002 CGS 15943 (dihydrochlori NSC632839 Y-27632 Eganelisib BRD-6929 Cambinol Empty de) (2R,5S)- b Empty 4E2RCat TPCA-1 CXD101 STAT3-IN-1 Ritlecitinib Ritlecitinib Toxoflavin HTHQ Ciliobrevin A 3-AP Empty c Empty BGP-15 NCB-0846 GS-444217 IWP-O1 BRCA1-IN-2 WT-161 KRIBB11 PF-1355 Bisantrene GCN2-IN-1 Empty Beaucage d Empty Acelarin BAY1082439 Simurosertib MX69 SAR-20347 ML364 CDD3505 CDD3506 CCCP reagent Empty 2,4-Diamino- Diphenylenei Adenosine 5′- L-NIO e Empty 6- odonium diphosphorib HA-100 (dihydrochlori Nrf2-IN-1 CCT251236 AG-494 Monastrol Salermide Empty hydroxypyrimi chloride ose (sodium) de) f Empty LY294002 SKL2001 CeMMEC13 RHPS4 AS-605240 KYA1797K IC-87114 TG100-115 PNU-74654 TGX-221 Empty PI-103 Tin- g Empty SF2523 PI-103 (Hydrochlorid 3-Bromo-7- Filibuvir C2 Ceramide protoporphyri BI 689648 Agmatine ZINC0088152 Empty e) nitroindazole n IX (sulfate) 4 Milademetan h Empty YKL-5-124 YKL-5-124 Barasertib- (tosylate Barasertib GDC-0326 EMT inhibitor- Thiomyristoyl ZM-447439 DMU2105 Empty (TFA) HQPA hydrate) 1 Plate layout: CS-L034-3 1 2 3 4 5 6 7 8 9 10 11 12 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com Veliparib Deoxycytidine a Empty DMU2139 Veliparib FK614 Paprotrain (dihydrochlori Hesperin triphosphate Cyclo(his-pro) Trolox RAD51 Empty de) (trisodium (TFA) Inhibitor B02 Trilaciclib GKT136901 b Empty AK-1 (hydrochlorid LF3 LY3214996 GKT136901 (hydrochlorid eIF4A3-IN-1 Cdc7-IN-1 HI-TOPK-032 GDC-0077 Empty e) e) Elimusertib c Empty Elimusertib (hydrochlorid Tozasertib MSC2530818 Olaparib Recilisib Ilaprazole LTURM34 RG-12525 TRC051384 Empty e) RG7800 d Empty IMD-0354 BTB-1 PHA-680632 EDO-S101 eIF4A3-IN-2 Danusertib RG7800 hydrochloride MLN8054 Laflunimus Empty CHIR-99021 CHIR-99021 Dihydrofluore e Empty CHIR-99021 (monohydroc (trihydrochlori AX-15836 STAT5-IN-1 scein Linsitinib Heparan Autophinib PI3Kδ-IN-1 Empty hloride) de) diacetate Sulfate N6,N6- f Empty AZD-1480 LY 345899 Wortmannin Deoxypseudo JAK3-IN-6 Dimethyladen BMS-754807 Rucaparib 6-Biopterin KY1220 Empty uridine osine (Camsylate) Retaspimycin g Empty Linperlisib Oxamflatin CDK9-IN-8 FM-381 STAT5-IN-2 Amuvatinib (Hydrochlorid Tanespimycin BIIB021 Luminespib Empty e) AKT Kinase h Empty Everolimus Rapamycin Vorinostat Ixabepilone CUDC-101 Panobinostat Belinostat Bortezomib GSK-690693 Inhibitor Empty Plate layout: CS-L034-4 1 2 3 4 5 6 7 8 9 10 11 12 SB 203580 a Empty NVP- AG1024 Sunitinib SB 203580 (hydrochlorid BAY 11-7085 BMS-536924 Omipalisib GSK-923295 HSF1A Empty ADW742 e) (+)-BAY- (±)-BAY- (-)-BAY- b Empty Gusacitinib 1251152 1251152 1251152 PIK-294 CMPD101 CLK1-IN-1 inS3-54A18 ROCK-IN-2 RSVA405 Empty 1- c Empty D4476 Ro 90-7501 Toyocamycin Monomethyl JNJ-7706621 Proglumide Aminobenzotr KW-2449 Stiripentol Tirbanibulin Empty fumarate (sodium) iazole Tirbanibulin Fasudil MK-2206 PROTAC Amifostine d Empty (dihydrochlori Tirbanibulin (Hydrochlorid AZD 6482 PI-273 AKT inhibitor (dihydrochlori GS-441524 CDK9 thiol Empty de) (Mesylate) e) VIII de) Degrader-1 (dihydrochlori Samuraciclib Samuraciclib e Empty GW779439X K00546 BI-6C9 PF-06409577 iCRT3 IBR2 (hydrochlorid (trihydrochlori PP121 ACY-957 Empty e) de) Fedratinib f Empty BAY 73-6691 tCFA15 MKC8866 Pamiparib LM22B-10 Lanifibranor CAY10602 Fedratinib (hydrochlorid TG101209 Empty e hydrate) g Empty AZ960 AZD-8055 OSI-027 Milciclib A-443654 Vismodegib Balapiravir R-1479 Pralatrexate Delanzomib Empty SCH- Melflufen h Empty TAK-715 Torkinib 1473759 Dinaciclib Cobicistat SC75741 Lexibulin (hydrochlorid FPL 62064 Tenidap Empty (hydrochlorid e) Plate layout: CS-L034-5 1 2 3 4 5 6 7 8 9 10 11 12 BMS-345541 a Empty Orteronel Rifalazil AR-A014418 BX795 (hydrochlorid BMS-345541 GSK1904529 Tasquinimod Betulinic acid SRT 1720 Empty e) A Gatifloxacin Y-27632 b Empty CYC-116 IMD-0560 DR2313 Pluripotin GSK 3 Gatifloxacin (hydrochlorid Flurbiprofen (dihydrochlori Valproic acid Empty Inhibitor IX e) de) Valproic acid Rucaparib c Empty (sodium salt) 5-Azacytidine TWS119 IQ 1 MMV390048 Liarozole A-966492 (phosphate) Rucaparib Niraparib Empty Niraparib L-Buthionine- L-Buthionine- Chloroquinox d Empty (hydrochlorid Niraparib Niraparib (R- (S,R)- (S,R)- Tefinostat Arimoclomol Tiaprofenic aline BMS-687453 Empty e) (tosylate) enantiomer) sulfoximine sulfoximine (maleate) acid sulfonamide Peldesine 6-Bromo-2- e Empty PKI-402 (dihydrochlori MAP4343 PF-AKT400 AZD4205 MTX-211 PQR530 Sulcotrione hydroxy-3- Tetrahydrobio Empty de) methoxybenz pterin 5- f Empty B I09 NU6140 Abrocitinib OSS_128167 (E/Z)-AG490 A 1070722 Oleoylethanol Guggulsteron Duocarmycin Methoxyflavo Empty amide e TM ne 4- 2-Phospho-L- g Empty Hydroxychalc ascorbic acid SCR7 LSN 3213128 FT671 GNE-6776 MK-3903 MSDC-0602 CCT 137690 GNE-493 Empty one (trisodium) pyrazine Bisindolylmal Empty eimide X Pemetrexed Pemetrexed Raltitrexed T- GC7 Sulfate Brequinar AG126 3-TYP IM-54 Empty h (hydrochlorid (disodium) 00127_HEV1 Plate layout: CS-L034-6 Address: 1 Deer Park Dr, Suite Q, Monmouth Junction, NJ 08852, USA Tel: 732-484-9848 Fax: 888-484-5008 Email: [email protected] • Bioactive Molecules • Building Blocks • Intermediates www.ChemScene.com 1 2 3 4 5 6 7 8 9 10 11 12 EB-47 a Empty GW 501516 Talazoparib TMPyP4 WAY 316606 TC-S 7005 (dihydrochlori BYK204165 C16-PAF PhiKan 083 PhiKan 083 Empty tosylate tosylate de) hydrochloride Parsaclisib b Empty URB-597 GeA-69 NGP555 JWG-071 SDZ285428 JFD00244 Tucidinostat Vamorolone Adavivint (hydrochlorid Empty e) c Empty Tegatrabetan Soticlestat Izencitinib Zandelisib Pifithrin-μ VER-155008 VER-82576 AZD1390 RG7112 Momelotinib Empty D4- Momelotinib ENMD-2076 d Empty abiraterone sulfate Alisertib MK-0752 CORM-401 Amonafide (Tartrate) ENMD-2076 AZD-7762 Adavosertib Empty (Z)- e Empty GSK429286A PHA-793887 CP-466722 GW843682X BX-912 TBCA KU-57788 Guggulsteron BTZO-1 CGP60474 Empty e TRAF-STOP f Empty TDZD-8 SP-141 BRD9876 inhibitor ML334 GS143 S3QEL-2 BAM 15 Apcin WAY-262611 Empty 6877002 PKI-179 g Empty GNE-477 Fingolimod WHI-P97 PKI-179 (hydrochlorid RO4929097 Corin Pilaralisib AZD7325 PIK-108 Empty e) analogue Casein h Empty Pyributicarb (E/Z)- ML351 AZD5904 HDAC8-IN-1 FT827 Tinoridine FN-1501 MK8722 Kinase II Empty GSK5182 hydrochloride Inhibitor IV Plate layout: CS-L034-7 1 2 3 4 5 6 7 8 9 10 11 12 SEL120-34A 1- JAK-IN-5 a Empty LX2343 (monohydroc SR-4370 MK-8353 EOAI3402143 SSE15206 Ethynylnapht CeMMEC1 GSK2643943 (hydrochlorid Empty hloride) halene A e) Mitochondrial 5-Aza-7- 2’-O,4’-C- b Empty Porcn-IN-1 fusion AZD-0364 PI3K/mTOR IPI-3063 Mitochonic AZ2 deazaguanin PluriSIn #2 Methyleneurid Empty promoter M1 Inhibitor-2 acid 5 e ine 3'-Azido-3'- 3'-Azido-3'- 3- N6-Etheno 2'- N2- c Empty deoxy-5- deoxy-beta-L- Methylcytidin deoxyadenosi Methylguanos 6-O-Methyl Gboxin CycLuc1 Tyk2-IN-5 Jaspamycin Empty fluorocytidine uridine e ne ine Guanosine 5-Iodo- Saccharin 1- d Empty NRX-252262 AZD-7648 ACY-1083 HO-1-IN-1 HO-1-IN-1 TH34 CK1-IN-1 indirubin-3'- GSK8612 methylimidaz Empty hydrochloride monoxime ole Chitosan GDC-0575 Lerociclib e Empty BAY885 AZD4573 oligosacchari GDC-0575 dihydrochlorid KO-947 O-304 CDK12-IN-3 (dihydrochlori FT895 Empty de e de) ERK1/2 Aurora kinase Aurora kinase f Empty inhibitor 1 C188-9 T025 AZ32 inhibitor-2 inhibitor-3 Sirt2-IN-1 NIK SMI1 UCT943 MF-094 Empty PNU112455A g Empty AZD3458 (hydrochlorid CC-90003 MC3482 Tubulin UCB9608 SMN-C3 BAY-2402234 Stafib-2 GCN2iB Empty e) inhibitor 1 V-9302 4'- h Empty CDDO- 4-Octyl V-9302 (hydrochlorid PF-06700841 BRD 4354 AGL-2263 TFAP Methylchryso EX229 Empty dhTFEA Itaconate e) (P-Tosylate) eriol Plate layout: CS-L034-8 1 2 3 4 5 6 7 8 9 10 11 12 Sulfosuccinim a Empty DK419 ON-013100 MBQ-167 idyl oleate Asp-AMS Mito-TEMPO IITZ-01 Grp94 mTOR GNE-6640 Empty (sodium) Inhibitor-1 inhibitor-1 Asymmetric 8- Se- b Empty 1- N-Oleoyl dimethylargini Hydroxyguan FAPy- Nudifloramide Protosappani 9-ING-41 Imrecoxib Methylseleno Empty Methylinosine glycine ne osine adenine n A cysteine NV-5138 c Empty LY3295668 NXT629 CCB02

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    12 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us